BICYCLE THERAPEUTICS PLC - Ordinary Shares, nominal value GBP 0.01 per share (BCYC)
CUSIP: 088786108
Q3 2019 13F Holders as of 30 Sep 2019
- Type / Class
- Equity / Ordinary Shares, nominal value GBP 0.01 per share
- Shares outstanding
- 50,351,032
- Total 13F shares
- 6,446,149
- Share change
- -189,067
- Total reported value
- $73,420,000
- Price per share
- $11.39
- Number of holders
- 11
- Value change
- -$1,907,302
- Number of buys
- 3
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 088786108?
CUSIP 088786108 identifies BCYC - BICYCLE THERAPEUTICS PLC - Ordinary Shares, nominal value GBP 0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 088786108:
Top shareholders of BCYC - BICYCLE THERAPEUTICS PLC - Ordinary Shares, nominal value GBP 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13F
|
Company |
3.9%
|
1,957,961
|
$19,697,000 | — | 30 Jun 2019 | |
| SV Health Investors, LLC |
13F
|
Company |
3.8%
|
1,915,274
|
$19,268,000 | — | 30 Jun 2019 | |
| Atlas Venture Advisors, Inc. |
13F
|
Company |
2.7%
|
1,362,696
|
$13,709,000 | — | 30 Jun 2019 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
1.5%
|
737,529
|
$7,420,000 | — | 30 Jun 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.28%
|
139,496
|
$1,403,000 | — | 30 Jun 2019 | |
| Polar Capital LLP |
13F
|
Company |
0.26%
|
130,000
|
$1,308,000 | — | 30 Jun 2019 | |
| Laurion Capital Management LP |
13F
|
Company |
0.2%
|
100,000
|
$1,006,000 | — | 30 Jun 2019 | |
| BlueCrest Capital Management Ltd |
13F
|
Company |
0.14%
|
70,000
|
$704,000 | — | 30 Jun 2019 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.13%
|
63,822
|
$642,000 | — | 30 Jun 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.11%
|
53,360
|
$537,000 | — | 30 Jun 2019 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.11%
|
52,900
|
$532,000 | — | 30 Jun 2019 | |
| NORGES BANK |
13F
|
Company |
0.1%
|
50,000
|
$503,000 | — | 30 Jun 2019 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,718
|
$17,000 | — | 30 Jun 2019 | |
| Catalyst Capital Advisors LLC |
13F
|
Company |
0%
|
460
|
$5,000 | — | 30 Jun 2019 |
Institutional Holders of BICYCLE THERAPEUTICS PLC - Ordinary Shares, nominal value GBP 0.01 per share (BCYC) as of Q3 2019
As of 30 Sep 2019,
BICYCLE THERAPEUTICS PLC - Ordinary Shares, nominal value GBP 0.01 per share (BCYC) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,446,149 shares.
The largest 10 holders included
TYBOURNE CAPITAL MANAGEMENT (HK) LTD, SV Health Investors, LLC, Atlas Venture Advisors, Inc., Aquilo Capital Management, LLC, VICTORY CAPITAL MANAGEMENT INC, BlueCrest Capital Management Ltd, Laurion Capital Management LP, Pentwater Capital Management LP, MILLENNIUM MANAGEMENT LLC, and NORGES BANK.
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2019 vs Q2 2019 Across Filers
Q2 2019 holders
14
Q3 2019 holders
11
Holder diff
-3
| Investor | Q2 2019 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q2 2019 Value $ | Q3 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.